
Last Price
52 Week Range
$0.51 - $3.22
Next Earnings Date
Mar 26 2026 (Estimate)
Next Earnings Date
Mar 26 2026 (Est.)
Last Price
Company Name | Form Type | Filed | View |
|---|---|---|---|
Spero Therapeutics, Inc. | 8-K | January 30, 2026 | |
Spero Therapeutics, Inc. | 8-K | December 19, 2025 | |
Spero Therapeutics, Inc. | 8-K | November 13, 2025 | |
Spero Therapeutics, Inc. | 10-Q | November 13, 2025 | |
Spero Therapeutics, Inc. | 8-K | August 12, 2025 | |
Spero Therapeutics, Inc. | 10-Q | August 12, 2025 | |
Spero Therapeutics, Inc. | 8-K | June 18, 2025 | |
Spero Therapeutics, Inc. | 8-K | May 28, 2025 | |
Spero Therapeutics, Inc. | 8-K | May 13, 2025 | |
Spero Therapeutics, Inc. | 10-Q | May 13, 2025 | |
Spero Therapeutics, Inc. | ARS | April 28, 2025 | |
Spero Therapeutics, Inc. | 8-K | April 28, 2025 | |
Spero Therapeutics, Inc. | DEF 14A | April 28, 2025 | |
Spero Therapeutics, Inc. | DEFA14A | April 28, 2025 | |
Spero Therapeutics, Inc. | 10-K | March 27, 2025 | |
Spero Therapeutics, Inc. | 8-K | March 27, 2025 | |
Spero Therapeutics, Inc. | 8-K | February 28, 2025 | |
Spero Therapeutics, Inc. | 8-K | January 10, 2025 | |
Spero Therapeutics, Inc. | 8-K | November 14, 2024 | |
Spero Therapeutics, Inc. | 10-Q | November 14, 2024 | |
Spero Therapeutics, Inc. | 8-K | October 29, 2024 | |
Spero Therapeutics, Inc. | 8-K | September 10, 2024 | |
Spero Therapeutics, Inc. | 8-K | August 5, 2024 | |
Spero Therapeutics, Inc. | 10-Q | August 5, 2024 | |
Spero Therapeutics, Inc. | 8-K | June 3, 2024 | |
Spero Therapeutics, Inc. | 10-Q | May 15, 2024 | |
Spero Therapeutics, Inc. | 8-K | May 15, 2024 | |
Spero Therapeutics, Inc. | DEFA14A | April 16, 2024 | |
Spero Therapeutics, Inc. | DEF 14A | April 16, 2024 | |
Spero Therapeutics, Inc. | ARS | April 16, 2024 |
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.